Enhanced Games valuation plunges $800m after underwhelming Las Vegas debut
Shares of the publicly traded organiser drop sharply as the company pivots focus from sport to pharmaceutical sales, with early business figures showing minimal income.
The inaugural Enhanced Games, held in Las Vegas on 24 May 2026, has resulted in a significant financial setback for its organiser, Enhanced. The company’s valuation plunged by nearly $800 million following the event, which was widely perceived as underwhelming despite its high-profile nature. The competition, which permitted the use of performance-enhancing drugs, took place in a temporary arena constructed in a casino parking lot at Resorts World.
The event featured a mix of outcomes that complicated its narrative as a showcase for human enhancement. Bulgarian-Greek swimmer Kristian Gkolomeev set a new world record in the men’s 50-metre freestyle with a time of 20.81 seconds, although the timing was disputed online. Conversely, clean athletes secured victories in other disciplines; American sprinter Fred Kerley won the men’s 100-metre sprint, and American swimmer Hunter Armstrong claimed the backstroke title.
Enhanced, now publicly traded on the New York Stock Exchange with an initial valuation of $1.2 billion, utilised the games as a promotional platform for its line of supplements and hormones. Despite the extensive marketing and the presence of high-profile athletes, the company reported minimal revenue from its enhancement business in early 2026. SEC filings revealed that the company generated only $2,755 in revenue from this sector in the first three months of the year.
The event was preceded by an eight-week clinical trial in Abu Dhabi for approximately 40 athletes, overseen by cardiologist Guido Pieles. This trial was part of an effort to standardise enhancement protocols, although the timeline was shortened from the original 12-week plan due to regional conflicts. The competition served to launch Enhanced Performance Products, a subscription-based line of peptides and hormones, marking a shift in the company’s strategy from pure sport to pharmaceutical sales.
Leadership changes also marked the period surrounding the games. Aron D’Souza, the original founder, has transitioned out of day-to-day operations, with Max Martin assuming the role of CEO. The company had previously filed an $800 million antitrust lawsuit against World Aquatics, WADA, and USA Swimming, which was dismissed by a New York court in November 2025. Enhanced has since announced a $10 million prize for anyone who breaks Usain Bolt’s 100-metre world record in 2027, signalling its intent to continue the venture despite the recent financial volatility.
